Let’s Answer the Questions About Marijuana

Much more research is needed to determine the benefits and risks associated with marijuana. Changing its drug classification from Schedule 1 to 2 will help.

I’ve written in the past about the unknowns of marijuana. We don’t have concrete proof confirming the medical benefits that cannabis proponents make. The “high” experienced is different every time for every person. We don’t have a way of measuring impairment that drug creates. There are many strains which all have differing effects and so much more.

It seems crazy, but marijuana is still classified as a “Schedule 1” drug according to the Controlled Substances Act. That means officially the US government’s stance on cannabis is that it has “no currently accepted medical use in the United States, a lack of accepted safety for use under medical supervision, and a high potential for abuse.” This puts it in the same group as drugs such as heroin, LSD and ecstasy.

We Need Research

Marijuana is believed to have many medical benefits but it also has side effects. There is evidence that it can help with pain, stimulate the appetite for people undergoing chemotherapy and treat glaucoma, Parkinson’s disease and seizures, but it is mostly anecdotal or observational in nature. To unleash all the benefits of marijuana and to make sure it is used safely, we need research.

But research is limited because legal access by scientists for study is restricted because it’s a Schedule 1 drug. It’s such a long and cumbersome process requiring paperwork from many different federal agencies that it discourages many researchers from even trying. The Drug Enforcement Agency (DEA) tightly controls access to marijuana for research and has just one main location, the University of Mississippi, where it is grown for this purpose.

Reassign Pot to Schedule II

A solution would be to reassign marijuana as a Schedule 2 drug. This would allow much more research to take place that we can find out if marijuana truly has all the benefits people are talking about and what the risks are. For more information on this topic, please read Pot Research: Why It Matters.)

At MedShadow Foundation, we’ve drafted a petition that will be sent to the DEA and other federal agencies asking them to change marijuana from a Schedule 1 to Schedule 2 drug, which will facilitate medical research on it. If you agree we need more research now, please, sign our petition. And share it with you friends and family too.


Suzanne B. Robotti

Suzanne B. Robotti

Suzanne Robotti founded MedShadow Foundation in 2012. Learn more about Su and her mission.


Did you find this article helpful?

No votes so far! Be the first to rate this post.


Latest News

Fish Oil and Semen, Belviq, HPV for Adults, Abortion Reversal Medicine

Fish Oil and Semen, Belviq, HPV for Adults, Abortion Reversal Medicine

Just when you thought you’d aged out of having to decide about HPV vaccination, more options are back for those up to 45 years old. Politics are driving a misinformation campaign on the so-called abortion reversal drug and risking women’s lives. What to do about declining semen quality in men?…

Hypertension, IBS, Hip Fracture and Multiple Meds

Hypertension, IBS, Hip Fracture and Multiple Meds

Two ways to avoid using drugs in the New Year: Lowering high blood pressure is a family affair and a nerve stimulator relieves the pain of IBS. Plus a bonus — 21 drugs that increase the risk of falls and subsequent hip fractures in seniors. Check the list! Hypertension, Blood…

  • Advertisement